Skip to content

Exercise in Pediatric Cancer Patient Undergoing Anti-Cancer Treatment

Physical Activity Intervention Program for Childhood Cancer Patients Under Chemo- and/or Radiation Therapy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02216604
Acronym
ONKOKIDS-HD
Enrollment
50
Registered
2014-08-15
Start date
2011-05-31
Completion date
2019-03-31
Last updated
2019-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood Cancer

Keywords

Exercise, Pediatric oncology, Physical Performance, Quality of Life, Feasibility, during primary, anticancer treatment

Brief summary

Today about 80% childhood cancer patients become long-time survivors. In spite of the high cure rates the diagnosis cancer is associated with a variety of disease and treatment-related psychological and physical impairments mostly present into adulthood. So the attention has to focus on the improvement of these problems such as motor limitation, dysfunction of the cardiovascular system, reduced muscle strength, overweight, osteoporosis and diminished quality of life (Qol). Although exercisel intervention studies in this field are generally scarce, the results of these studies are promising. Up to now studies during the acute phase of treatment are missing almost completely. The aim of this feasibility study is to evaluate the potential benefits of a modular exercise intervention program for childhood cancer patients startunf in parallel with treatment and longlasting for one year. Across two years cancer patients of the Children's Hospital of the University Clinic of Heidelberg aged 5-21 years, free of any contraindications for physical activity will be recruited. All participants are asked to complete a physical assessment battery (strength, endurance and balance capacity, posture control, functional mobility, range of motion) and additionally two questionnaires concerning Qol and motivation, at baseline and every three months following one year

Interventions

During their inpatient hospitalization the participants perform 3-5x weekly guided training sessions about 15-30min. The intervention includes: game console-based training using Nintendo Wii® (endurance, strength endurance and balance), age-specific resistance training and sessions of body awareness. During the outpatient phases the participants perform a home-based exercise training 3-5x weekly using a training manual. In addition, the patients obtain a movement diary and a pedometer for documenting their activity level.

Sponsors

University Hospital Heidelberg
CollaboratorOTHER
Heidelberg University
CollaboratorOTHER
University of Leipzig
CollaboratorOTHER
Children's Medical Hospital, University of Leipzig, Leipzig, Germany
CollaboratorOTHER
German Cancer Research Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

* pediatric cancer diagnosis (primary leukemia, brain tumors and bone tumors * date of diagnosis not longer than 8 weeks ago

Exclusion criteria

* severe cardiac impairment * bone metastasis inducing skeletal fragility * other orthopedic diseases or any other circumstance that would impede ability to give informed consent or adherence to study requirements.

Design outcomes

Primary

MeasureTime frameDescription
Feasibility after 6 monthafter primary treatment (6 month)Will be measured as the proportion of patients following the exercise prescription.

Secondary

MeasureTime frameDescription
Physical performanceafter primary treatment (6 month) and after one yearStrength (handheld dynamometer), endurance and balance capacity (TUDS, one leg stand), postural control functional mobility (posturomed & force plate), range of motion (goniometer)
Quality of Lifeafter primary treatment (6 month) and after one yearKINDL questionnaire
Feasibility between 6 and 12 monthbetween end of primary treatment (6 month) and one yearWill be measured as the proportion of patients following the exercise prescription.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026